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Background: New Zealand has one of the highest rates of obesity and obesity-related 
diseases in the world. Claims have suggested that a low glycaemic index diet will curb 
cravings to overeat by keeping you feeling fuller for longer. However, there is conflicting 
data regarding the relationship between GI and satiety. 
Objective: To determine the effect on measures of satiety and blood glucose of two test 
foods with different glycaemic indices but otherwise identical composition within a healthy 
New Zealand adult population.  
Design: Randomised double-blinded crossover control trial. The main contribution of this 
study is to present novel findings in relation to the ongoing scientific glycaemic index 
debate through the consistency of altering one variable only in humans over a two day trial.  
Methods: Seventy-seven participants were randomised to receive the isomaltulose- and the 
sucrose-sweetened trifles over two testing days, with two to three weeks in between. Only 
the glycaemic index differed between trifles so that any differences could only be attributed 
to the rate of digestion of the sugars. Blood samples were collected at baseline, 60 and 120 
minutes and were analysed for blood glucose. Subjective satiety was measured using a four-
question visual analogue scale questionnaire at baseline, 30, 60, 90, 120 and 150 minutes. 
Weighed diet records were used to obtain subsequent energy intake for comparison between 
the trifles.  
Results: Blood glucose rose at 60 minutes then declined at 120 minutes, though remained 
above baseline for both trifles. A statistically significant difference between trifles was 
observed at 60 minutes following consumption, with a difference of 0.69 mmol/L (95%CI: -
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1.12, -0.25; p<0.05). Mean satiety AUC did not significantly differ between the 
isomaltulose- and sucrose-sweetened trifles. There was also no significant difference in 
subsequent energy intake between the trifles, though there was a tendency for increased 
energy intake following the consumption of the isomaltulose-sweetened trifle (364kJ, 
95%CI: -110, 838; p=0.133). 
Conclusion: No significant differences were found between the trifles for satiety or 
subsequent energy intake. Under our test conditions, the glycaemic response was not related 
to satiety or subsequent energy intake.  
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1. Introduction 
Suggestions have been made that foods with a low glycaemic index (GI) keep you feeling 
fuller for longer and prevent weight gain by suppressing tendencies to overeat (1). GI is 
defined as a measure of the glycaemic response exhibited by carbohydrate-containing foods 
(2). It has been indicated that low GI foods are absorbed more slowly into the bloodstream 
and have a better glycaemic response compared to high GI foods (3). As a result, the 
consumption of low GI dietary carbohydrate has been associated with a reduced relative risk 
(4) and improved control (5) of type two diabetes mellitus (T2DM); and a reduction in the 
risk of cardiovascular disease (6).  
 
In a country where over 32% of adults are currently obese (7) (with a body mass index 
(BMI) of >30kg/m2 (7)), New Zealand’s growing waistlines have resulted in what has been 
described as an obesity epidemic (7). Furthermore, excess weight is known to be a key 
modifiable risk factor for several non-communicable diseases such as T2DM and multiple 
cancers (7). Unfortunately, health professionals have not yet reached a unanimous decision 
as how best to address this growing issue. However, advocates for a low GI diet argue that 
choosing low GI carbohydrates will ensure weight loss (5) and the maintenance of a stable 
weight (8); and should therefore be incorporated into widespread public health messages (9).  
 
In order to test the effects of foods with different glycaemic indices on satiety and 
subsequent energy intake, the current study will use isomaltulose as a low GI sucrose 
alternative to generate a difference in glycaemic response between test foods. Isomaltulose 
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is a sugar which is found in trace amounts naturally in honey and cane juice (10), and is 
added to processed foods in larger quantities (11). The disaccharide, also known by its trade 
name Palatinose™ (12), has a lower GI than sucrose (32 (12) versus 72 (13), respectively). 
Isomaltulose has been used in Japan since 1985 in products such as confectionary, chewing 
gum and yoghurt (14) as a non-cariogenic, low-glycaemic sugar (15). A number of 
toxicology animal studies ((15), (16)) have been carried out. These determined a safe level 
of consumption so that further human trials could be undertaken in order to measure other 
end-points such as plasma glucose and insulin levels. Many of these human studies, 
however, utilised isomaltulose in a single-dose solution (17); and a small sample size ((18), 
(19)). Isomaltulose has since been approved by Food Standards Australia New Zealand in 
2007 for use in New Zealand as a low GI sucrose alternative in products such as breakfast 
cereals and soft drinks (11). Both sucrose and isomaltulose contain glucose and fructose, 
though this does not explain sucrose’s different rate of digestion of its monomers. This is 
important because GI studies are often confounded by comparison foods having different 
composition of protein, fat and fibre, factors that may independently affect the relationship 
between the food and satiety. This confounding may in part explain conflicting data (20) 
regarding the relationship between GI and satiety ((21), (22)). Therefore, the main 
contribution of this study is to present novel findings in relation to GI and satiety when all 
food factors, apart from the rate of digestion of the sugar, have been controlled for. Hence, 
the purpose of the current study is to determine the effect on measures of satiety and blood 
glucose of two test foods with different glycaemic indices but otherwise identical 
composition within a healthy New Zealand adult population.  
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2. Literature Review 
 
2.1 Methodology of this Literature Review  
 The objective of this literature review is to determine whether a low glycaemic index food 
keeps you fuller for longer. 
This literature review aims to:  
1. Provide an overview of isomaltulose, isomaltulose biochemistry, isomaltulose 
metabolism and current uses of isomaltulose;   
2. Discuss the current literature regarding isomaltulose, glycaemic index and satiety; 
   
Literature was obtained from Medline via Ovid. Keywords included were ‘isomaltulose’, 
‘glycaemic index’, ‘adult’, ‘sucrose’, ‘glucostatic theory’, ‘satiety’ and ‘dietary sucrose’. 
Further literature was obtained from the reference lists of the published articles that had 
been previously identified.  
 
2.2 Rationale for research 
Carbohydrate-rich foods contribute to a significant proportion of daily energy intake and are 
a staple part of the diet in many cultures, both in the developing and Western world. 
Targeting those individuals who want to lose weight or manage their non-communicable 
disease, claims have been made to promote certain carbohydrates to improve their health 
outcomes, namely those carbohydrates with a low GI (1). However, the validity of these 
claims are becoming increasingly important as rates of obesity in New Zealand have 
increased over recent years (7).  
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Despite the considerable literature surrounding the effect of GI on satiety, a unanimous 
decision has not yet been reached as to whether low GI foods do in fact live up to their 
supposed health benefits. Possible reasoning for this is due to the presence of confounding 
variables. Therefore, the current study is novel in that only the GI will differ between trifles 
so that any differences can only be attributed to the rate of digestion of the sugars.  
2.3 Isomaltulose 
2.3.1 What is Isomaltulose?  
Isomaltulose (Palatinose™) is a disaccharide carbohydrate made up of glucose and fructose 
monomers (Figure 2.1) (1). Despite its similarities in taste and appearance to sucrose (2), 
isomaltulose is only half as sweet (1) as sucrose (table sugar) and contains alpha-1,6 bonds, 
compared to the alpha-1,2 bonds of sucrose (3).  
Figure 2.1 Chemical structure of isomaltulose (1) 
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Isomaltulose is found in trace amounts in honey (1) and sugarcane juice (1). More 
significantly though, isomaltulose is manufactured using sucrose isomerase (Figure 2.2) 
which converts the alpha-1,2 bond of sucrose into an alpha-1,6 bond (1, 3). This mechanism 
efficiently produces isomaltulose as the main product of the reaction (4). Commercial 
production of isomaltulose has resulted in its use as a sugar in Japan since 1985 (2). 
Isomaltulose has been regarded as safe in the United States of America and has been 
approved in the European Union (5), but is not yet readily available in New Zealand. 
Although there are many sucrose alternatives currently available on the New Zealand 
market, most are sweeteners rather than table sugar replicas. Therefore, there is a gap in the 










 Figure 2.2 Sucrose isomerisation and hydrolysis catalysed by sucrose isomerase (2) 
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Isomaltulose has a lower GI (explained in Section 2.5.1) (6) than sucrose, though it is still 
completely digested and absorbed in the small intestine (5). Holub et al. (5) was the first 
study to examine the digestibility and absorption of isomaltulose in vivo in humans, as there 
was little human research prior to 1985 (7). Isomaltulose has been extensively studied in 
rats, dogs and pigs (2). Noteworthy conclusions from these studies include the discovery 
that pregnant and non-pregnant rats can tolerate isomaltulose in up to 10% of total daily 
energy intake for 13 successive weeks with no adverse symptoms ((8), (9)). More recently 
though, the ingestion of isomaltulose was found to result in significantly less 
hyperlipidaemia, hyperglycaemia, visceral fat mass, pancreatic islet hypertrophy and 
adipocyte cell size in rats, compared to sucrose (10). Through natural temporal progression, 
isomaltulose animal studies have now been superseded by human trials after being deemed 
safe for human consumption at normal doses (2). Subsequent trials have used isomaltulose 
for the purpose of evaluating the metabolic effects of the sucrose alternative in humans 
((5),(11)). Compared to sucrose, isomaltulose is more appealing to food marketers (1) as a 
low GI, non-cariogenic (1) sugar. Dental caries place a significant burden on the modern 
healthcare system (ref). Compared to sucrose, isomaltulose is used by oral plaque bacteria 
to a much lesser extent (8) and it has been shown to decrease counts of caries-inducing 
Streptococcus mutans in saliva when compared to sucrose (12). Additionally, isomaltulose 
elicits a slower rate of digestion (13) and a decreased postprandial blood glucose and insulin 
response (5).  
 
	 	 	7	
2.4 Digestion of sugars 
Dietary sugars are digested and absorbed in the small intestine (29). Monosaccharides, such 
as glucose and fructose, are directly absorbed into the small intestine. Whereas, a 
disaccharide’s glycosidic bond needs to be hydrolysed first in order to release its 
monosaccharides as they are too large to be directly absorbed (29).  
 
Intestinal glucosidases cleave both sucrose, containing a 1,2-disaccharide bond, and 
isomaltulose, containing a 1,6-disaccharide bond, though the latter more slowly (16). The 
alpha-1,6 bond is present in natural food sources, such as honey, so humans have the 
mechanism to hydrolyse the bond, albeit at a slower rate than the 1,2 bond (16). Similarly 
though, isomaltulose and sucrose are both made up of glucose and fructose monomers (11). 
However, this does not explain the differences found between sucrose and isomaltulose on 
blood glucose and plasma insulin concentrations (17).  
 
Most of the carbohydrates consumed in the Western world are in the form of sucrose and 
starch (33). Starch is comprised of 85% amylopectin and 15% amylose (33). Amylose has a 
straight chain structure due to its alpha-1,4 bonds, whereas amylopectin has both alpha-1,4 
and alpha-1,6 bonds in a bridge-like structure (33). As a result, amylopectin’s formation is 
harder to break down into its individual constituents (glucose monomers) during the 
digestion of starch (33). Starch digestion begins in saliva but is said to predominantly occur 
in the lumen of the small intestine by pancreatic alpha-amylase (33).  
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The enzymes required to hydrolyse the end products of pancreatic alpha-amylase digestion 
are found within the brush border of the small intestinal mucosal cells (34). Pancreatic 
alpha-amylase has been shown to hydrolyse only the alpha-1,4 linkages, as the alpha-1,6 
linkages remain intact (33). However, isomaltase is able to cleave the alpha-1,6-bond within 
the alpha-limit dextrins. Isomaltase and sucrase are glucogenic intestinal brush border 
enzymes which cleave isomaltulose and sucrose, respectively (35).  
 
Carbohydrate digestion occurs in two stages: the luminal phase, which involves pancreatic 
alpha-amylase, and the membrane phase, which involves intestinal disaccharidases (14). 
Disaccharidases are located on the terminal membrane of the brush border and hydrolyse 
the end products of pancreatic alpha-amylase digestion (33). This is responsible for the 
release of fructose and glucose as the constituents of sucrose, by the action of sucrase (14). 
Carbohydrate digestion subsequently continues at the brush border where carbohydrate 
specific enzymes (disaccharidases) act on their corresponding disaccharides to cleave them 
into monosaccharides to be utilised by the body (14). This is evident through the action of 
the sucrase-isomaltase enzyme on both isomaltulose and sucrose (14). 
2.4.1 Digestion and Absorption of Isomaltulose  
Holub et al. (5) was one of the first studies to examine the digestibility and absorption of 
isomaltulose in humans. Like sucrose, isomaltulose is absorbed in the small intestine, 
though at a slower rate (2). This contact of nutrients with the small intestine is, in turn, 
responsible for evoking the satiety mechanism that lower GI foods have been suggested to 
prolong (15). Isomaltulose undergoes slow hydrolysis of its alpha-1,6-glycosidic bond by 
the sucrase–isomaltase complex, which is located on the brush border membrane of small 
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intestinal cells (2). Despite its rate of hydrolysis, absorption of the fully digestible 
carbohydrate is efficient (16).  
2.5 Glycaemic Response and Satiety 
2.5.1 Glycaemic Index 
GI, first proposed by Jenkins et al. (17), measures the effect of carbohydrate-containing 
foods on blood glucose (17). Additionally, the numerical classification can be statistically 
defined as the incremental area under the curve (iAUC) for blood glucose (18). Consumers 
and healthcare professionals alike are becoming more interested (19) in this model as a 
means to objectively measure dietary carbohydrate intake. GI is gaining a growing profile 
through its increasing use in marketing claims by the food industry (20). However, 
associations have been made in favour of ((21) (22), (23), (24), (25), (18), (26)), and in 
disagreement of ((27), (28), (29)) the proposed health benefits of a low GI diet. 
Consequently, the GI notion has sparked global debate (30) as to whether it is a viable 
measure of health. There is little, but conflicting, evidence regarding the importance of the 
type of carbohydrate on satiety and therefore energy balance (30).  
In order to determine the GI of a food, a portion of food containing 50g of carbohydrate is 
usually given to at least 10 test subjects over a 120-minute time period (20). However, 
rather than being based on the subject’s physiological response to the food, the GI measure 
is claimed to derive solely from the properties of the food (i.e. the area under the curve 
(AUC) for the 50g of carbohydrate) (17). This is due to the fact that the core predictor of the 
food’s GI is its carbohydrate digestion factor (31). GI is a relative glycaemic response 
depending on how blood glucose levels are influenced. Therefore, the AUC of blood 
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glucose is written as a percentage of the ‘standard’ test food (24). Although, it is possible 
that GI is limited in a realistic setting as in a mixed meal, the differences in GI between 
foods becomes redundant (32).  
Carbohydrates with a lower GI have been said to undergo a delayed rate of glucose 
absorption from the small intestine, triggering a reduction in the postprandial rise of gut 
hormones and insulin. As a result, the blood glucose response is suppressed and glucose 
cellular uptake increases (24). A food’s glycaemic response is affected by many factors 
including its monosaccharide composition, and other food components such as fat and 
protein (33). The rate that a food is digested may be a key factor of its glycaemic response 
(17). Previous literature (34) suggests that the rate of glucose absorption can affect the 
feeling of hunger and satiety. 
From a literature search, the results from numerous short term studies (i.e. those that 
reported findings from a single meal or day) ((35), (36), (37), (38), (39), (40), (28)) showed 
decreased subsequent hunger and/ or increased satiety after the ingestion of low GI foods 
compared to the ingestion of high GI foods. These results were predominantly obtained 
from objectively measured energy intake or a subjective visual analogue scale (VAS) 
questionnaire. However, only one other study (40) measured the GI of the test foods prior to 
undertaking the experiment.  
 
Interestingly, Holt et al. (28) proved that boiled potatoes, a high GI food, produced a 
significantly higher satiety index (SI) score than croissants, also a high GI food, by 7 fold. 
An AUC measure was used to validate each food in relation to white bread. Additionally, 
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subjects acted as their own control within each food group, which allowed the unique study 
design to be a prominent strength of the trial. Therefore, the evidence can be considered the 
best available to date. Furthermore, in accordance with the current study, Holt et al 
measured subjective satiety using a 100mm VAS questionnaire (28). Findings showed that 
SI scores had a positive correlation with fibre, protein and water content. As a result, it has 
been suggested that the rate of digestion and the glycaemic response influence the feeling of 
fullness (41).  
 
2.5.2 Satiety 
Satiety is a short term factor (41) that defines the feeling of fullness after eating (40). Satiety 
is measured through its ability to suppress hunger for a certain time period following the 
cessation of consumption until the next meal (42). There are various objective and 
subjective measures of satiety. Although there is currently no universal measure of satiety 
(40), the most reliable method is thought to be through analogue rating scales (40). The 
VAS is a validated, subjective measure of satiety (43). Visual analogue scales are 
commonly used to evaluate subjective appetite signals and are comprised of lines of varying 
length containing phrases of extreme opposition at each end (43). Subjects allocate a mark 
along the continuum to represent the degree to which each phrase aligns with their degree of 
hunger (43). Satiety can be objectively measured using three biomarkers: decreases in blood 
glucose within a 5 minute period, leptin changes within a 2-4 day period negative energy 
balance, and ghrelin concentrations (44).  
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Satiety differs from satiation. Satiation is responsible for restricting meal size through its 
ensuing actions that lead to subsequent meal termination (41). Satiety on the other hand, 
influences meal frequency as it is responsible for the postprandial events that affect the 
duration between meals (41).  
 
A noteworthy element of the complex mechanism that influences energy intake is insulin, 
which acts to regulate both long-term food intake and short-term satiety (45). When the 
brain senses lower insulin levels, the hormone elicits a hunger response in search of an 
energy source (45).  
 
2.5.3 Glucostatic Theory 
The glucostatic theory is a well-known hypothesis in the literature that was initially 
described by Mayer (34). Mayer proposed that a low blood glucose concentration stimulates 
hunger and the onset of feeding, whereas a high blood glucose concentration stimulates 
satiation signals to cease feeding. This theory is derived from the concept that one’s appetite 
is stimulated when glycaemia drops below a “static” level (46). However, Holt et al. (40) 
have since suggested that the higher the meal’s glycaemic response, the lower the subject’s 
satiety, which therefore opposes the theory. Findings from Leathwood et al. (35) supported 
this postulation. They showed that compared to a meal containing potato purée (a high GI 
food), the same meal substituted with bean purée (a low GI food) elicited a lower glycaemic 
response and subjective satiety. Speculations by Leathwood et al. attributed these findings 
to a combination of factors including gastric sensations and the rate of glucose absorption.  
 
	 	 	13	
It is likely however, that in the few studies that have investigated the glucostatic theory, the 
validity of their study designs have to be considered. In an early trial by Bernstein et al. 
(47), rather than the participants themselves, the interviewers filled-in the appetite 
questionnaires. Additionally, in contrast to the current study, satiety questionnaires were 
filled in hourly following breakfast consumption. This was ensued by treatment 
administration where questionnaires were completed in 20-minute intervals. Blood samples 
were taken just before the treatment, just before the meal (30 minutes later) and 
immediately after the test meal. Therefore, there may have been a crossover of satiety 
responses between the treatment and food intake.  
 
Stunkard (48) pointed out two major flaws in the aforementioned theory: 1) the concept 
over simplifies the complex processes that are associated with eating; 2) the theory 
wrongfully assumes that satiety cues are linked to nutrient absorption in the period 
immediately following food intake. For the level of satiety felt immediately following 
ingestion, it is not viable that a significant caloric intake has been absorbed during that time. 
Therefore, the theory exists but is now outdated. The current study will use a larger sample 
size to test the hypothesis. Bernstein concluded from his findings that arterial, venous and 
arterio-venous blood glucose differences had no effect on appetite. Thus, the results of the 
experiment do not support Mayer’s glucostatic theory, and therefore, other factors must 
contribute to feelings of fullness and hunger. 
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2.6 Glycaemic Response and Satiety 
A few intervention studies ((28), (49)) have shown that GI does not appear to significantly 
affect satiety. Thirty-nine healthy adult subjects showed that there were no significant 
differences in satiety between groups (low GI and high GI) for hunger, fullness, or desire-
to-eat ratings (49). An impressive difference in GI (43.81 ± 0.99 and 105.26 ± 5.74, for high 
GI and low GI respectively) was elicited between groups. Forty-eight test foods were used 
that were representative of a typical Western diet. These included spaghetti, pizza, yoghurt 
and quiche. However, the differing energy and macronutrient content between test foods is 
likely to have confounded the results. Therefore, further investigations are warranted. Thus, 
the current study is an essential addition to the literature.  
 
In contrast to the findings by Alfenas et al. and Holt et al., a randomised controlled trial by 
Anderson et al. (32) showed that compared to a low GI beverage, an isovolumetric high GI 
beverage suppressed energy intake after 60 minutes. Additionally, blood glucose was 
measured at irregular intervals following consumption. However, in accordance with the 
current study, a VAS questionnaire was completed at regular intervals to measure feelings 
of hunger and satiety. An inverse relationship was observed between blood glucose 
concentration and food intake at 60 minutes (P<0.05); and subjective appetite (P<0.05). 
However, these findings must be approached with caution as subsequent energy intake was 
obtained through the provision of a single food (pizza) by the study coordinators at 
participant request only. Furthermore, the sample size was small (n=14) and only included 
18-35 year old healthy males.  
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Due to the inconsistency of the results by Alfenas et al., Holt et al. and Anderson et al., a 
clear conclusion cannot be drawn from these intervention studies, especially since study 
sample sizes were small and the study designs had limitations.  
 
As shown in Table 2.1, only one other study (40) measured the GI of the test foods prior to 
undertaking the experiment, as opposed to using pre-set values from external sources. Thus, 
the validity of the values in association to the test foods can be questioned. Therefore, the 
strength of the results from the current study have a design advantage in comparison to 
those findings from other trials. In addition, only one other study compared was randomised 
(38); or double-blinded (35). Both of these are crucial aspects in producing an unbiased trial 
as preconceptions based on suggested claims that low GI foods keep you feeling fuller for 
longer (50) may influence the results. Additionally, a power calculation was not present in 
any of the seven other trials. This was a key advantage of the current study as it mostly 
eliminated findings due to chance through the knowledge of the sample size required. This 
is especially important as the majority of studies conduct their trials knowing what the main 
outcome is that they would like to achieve. Furthermore, the majority of trials did not utilise 
either isocaloric or equal macronutrient test foods, thus influencing the results with 
confounding factors. Therefore, the current trial is novel in that all study design limitations 














Conclusions from this literature review suggest that on its own, GI is not an absolute 
determinant of feelings of hunger or satiety. Study design limitations and small sample sizes 
prevent current evidence from drawing clear conclusions about the effects of GI on satiety 
alone. Therefore, a more robust trial using isocaloric, equal macronutrient test foods is 




3. Objective Statement 
The aim of this study was to assess the effects of postprandial glycaemia on satiety. 
The study objectives are: 
• To test the effects of foods with different glycaemic indices on satiety. 
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Sucrose-sweetened trifle (n=37) 
 















Declined to participate (n=6) 
Withdrew  
Disliked trifle (n=2) 
 
Withdrew 
Disliked trifle (n=2) 
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2nd testing day 
 
Sucrose-sweetened trifle (n=35) 
 





Excluded from analysis (n=3) 
 
Fig. 1 CONSORT cross-over randomised control trial study design and participant flow diagram 
Figure	4.1	CONSORT	crossover	randomised	control	trial	study	design	and	participant	flow	diagram	
	 	 	20	
4. Subjects and Methods 
4.1 Methods  
Data collection took place in the Human Nutrition Undergraduate Laboratories at the 
University of Otago (Dunedin, New Zealand) between March 3rd and March 31st, 2017. The 
University of Otago Human Ethics Committee approved this study on 8th February 2017 
(number 17/011) (Appendix A). The current study undertook Māori consultation through 




Participants from this study were a convenience sample of undergraduate human nutrition 
students from the University of Otago (Table 5.1). An information sheet was provided to all 
participants both in advance of the first testing day and during the session. All subjects gave 
informed consent before undertaking this study. There were no participant exclusion criteria.  
 
4.3 Randomisation and Allocation 
Seventy-seven participants were randomised to receive either the sucrose- or isomaltulose-
sweetened trifle, in a cross-over design. Thirty-seven participants were randomised to 
receive the sucrose-sweetened trifle first and 38 participants were randomised to receive the 
isomaltulose-sweetened trifle first. A possible source of variability between sexes was 
controlled for using block randomisation to ensure equal sex distribution for the order in 
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which the trifles were consumed. Stata Statistical Analysis Software (version 13.1, Stata 
Corporation 2008) was used to randomise participants. A PhD student from the Department 
of Human Nutrition coded the trifles such that the study facilitators and participants were 
blinded to trifle type throughout the entirety of data collection.  
 
As males were a minority of the sample population (n=7), block randomisation was used to 
ensure they were evenly distributed between groups. Participants were also adjusted for the 
the order in which they received their trifles.  
 
4.4 Study Design 
As shown in Figure 4.1, the current study was designed as a double-blinded randomised, 
controlled crossover trial. The relationship between postprandial glycaemia and satiety was 
assessed, as well as the relationship between postprandial glycaemia and subsequent energy 
intake. Blood glucose concentrations and subjective satiety scores were measured at 
baseline and up to 120 minutes following the consumption of the trifles.  
 
Participants acted as their own controls as they received both trifles on separate occasions. 
Individual trifle portions were served in opaque red cups so that any visual differences 
between the trifles could not be detected by the participants (the sponge in the isomaltulose-
sweetened trifle tended to be a darker shade than the sucrose-sweetened sponge). Therefore, 
the double blinded study design was maintained throughout data collection. Participants 
were allocated 20 minutes to consume the trifle. If a participant was unable to eat the full 
portion in this time, the trifle container was marked with a line to indicate the amount of 
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trifle remaining. When the participant consumed the second trifle, he or she was asked to eat 
to the line to ensure the amount of trifle eaten was the same on both days.  
 
Note: As part of this study, another Master of Dietetics (MDiet) student tested memory and 
general executive function following the consumption of the trifles. However, the results are 
not included in this thesis.  
 
4.5 Test Food 
Trifles were chosen as the test food to optimise the amount of sugar whilst providing a 
palatable food (Appendix B). This in turn was expected to optimise any differences in 
glycaemic response between the trifles. The remaining ingredients were identical between 
the trifles, hence, any differences in glycaemic response could only be attributed to the 
sugars as all other variables were controlled for.  
 
The nutritional compositions of the trifles were obtained through the use of The Concise 
New Zealand Food Composition Tables1. Values are presented in Table 4.1. Both trifles 
contained exactly the same energy and macronutrient content, with the only difference 
being the type of sugar used. Weights of sponge, jelly and custard were standardised such 
that the composite trifle weighed 446g (Appendix C). Nine special diets were catered for 
on request by modifying the basic trifle recipe (Appendix D). Though specific dietary 
requirements affected the macronutrient composition and energy content of the trifles, total 
carbohydrate content remained consistent throughout. Therefore, the primary aim of the 
current study was to change only the rate of digestion of the sugars. 
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The sucrose- and isomaltulose-sweetened trifles were analysed by Dr. John Monro at the 
Food Industry Science Centre in Palmerston North, New Zealand. Trifles containing 50g of 
available carbohydrate were tested for their intrinsic carbohydrate content. This enabled the 
two MDiet students to calculate the quantity of jelly, sponge and custard required to 
generate a standard trifle serving that contained 98.2g of available carbohydrate. The total 
available carbohydrate per serving of trifle was generated as a result of the intention to 
generate the largest differential in glycaemic response whilst maintaining a practically 
manageable portion size.   Actually from table 4.1, the avail CHO was 98.2g and 80.5g is 
sugars. We wanted to optimise the amount of added sugar in each trifle to generate the 
largest differential in glycaemic response whilst maintaining a practically manageable 
portion size. 
 
Testing for Glycaemic Index of the trifles was conducted in 12 people by Glycemic Index 
Otago, an accredited Glycemic Index testing laboratory at the University of Otago. The 
portion of trifle for GI testing contained 50g available carbohydrate, and the postprandial 
responses represented by incremental AUC (iAUC) were compared against the average of 
three tests of a 50g glucose beverage. GI values of 33 and 44 were obtained for the 






*CHO = carbohydrate 
4.6 Study Procedure 
4.6.1 Data Collection 
Participants attended two testing days on different Fridays, with either two or three weeks in 
between. This gap between sessions was for logistical reasons as well as to mitigate any 
possible recollections of the taste and palatability of the trifles.  
 
4.6.2 Testing Day Procedure 
In order to maintain consistency, participants chose a brand and amount of breakfast cereal 
to eat on the morning of each testing day. This enabled the candidate to control for appetite 
and energy intake prior to the session. Following ingestion of their chosen breakfast cereal, 
participants were asked to abstain from consuming extra food or drink prior to the session. 
This was to ensure that participants were sufficiently hungry upon arrival. However, if 
additional food and/ or beverages were ingested during this time, participants were asked to 
consume those same items on their second testing day. Instructions were given for breakfast 
cereal consumption to occur at the same time on each testing day. All food and beverages 
consumed throughout the day, including those ingested prior to the session, were recorded 
																																																								
1 The Concise New Zealand Food Composition Tables, 11th Edition; 2014 

















Trifle 2601 15.8 18.6 98.2 80.5 73.2 0.6 
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on a weighed diet record sheet (Appendix E). This ensured that all food and drink 
consumed on the morning of the participant’s first session was also consumed on the 
morning of their second session. This record was later entered into the online database Kai-
culator.  
 
Upon arrival on their first testing day, all participants (n=75) completed a baseline 
demographic survey and dietary restrictions questionnaire (Appendix F). Participants then 
signed a consent form to participate in the study (Appendix G). The testing days ran from 
12 noon to 3:40pm. A session facilitator used stop watches in combination with a scheduled 
timeline in order to maintain timing consistency throughout the sessions. Water was 
provided during the testing days and participants were encouraged to replicate their intake 
across both sessions.  
 
Single weight and height measurements were taken for each participant by a trained 
research assistant. These measurements were used to calculate body mass index (BMI = 
weight (kg) divided by height squared (m2)). A calibrated Seca alpha scales (model 770) 
(Germany) was used to take weight measurements and a calibrated Holtain limited 
stadiometer (United Kingdom) was used to take height measurements.  
 
4.6.3 Sample Collection 
Finger-prick capillary blood samples were taken at baseline and subsequently at 60 and 120 




Prior to each testing day, collection tubes were pre-labelled with the participant’s 
identification number and the time of blood collection. Tubes were also identically labelled 
for plasma sample collection following centrifugation. Two days before each session, 10µl 
of potassium EDTA (sourced from the University of Otago), an anti-coagulant, was added 
into each tube. By removing the lids and placing an A4 piece of paper on top, the collection 
tubes were left to dry.  
 
A 500µl capillary blood sample was taken at baseline, then again at 60 and 120 minutes 
following the consumption of the trifles. Blood collection was undertaken at 60 and 120 
minutes to coincide with expected differences in glycaemic response. Trained study 
facilitators followed a standard blood sampling procedure for blood collection. Peripheral 
blood flow was increased by applying heat to the hands, then fingers were sanitised with 
alcohol wipes. Fingers were pricked using a BD microtainer® contact-activated 2.0x1.5mm 
disposable blue lancet. The first drop of blood was not used as it may have been 
contaminated or diluted by the alcohol wipe. Subsequent whole blood was extracted into 
Microcentrifuge collection tubes for analysis.  
 
Following blood collection, the sample tubes were inverted gently seven times. This ensured 
that the blood sample was fully mixed with the EDTA in order to prevent the blood from 
clotting. The tubes were centrifuged for 10 minutes at 2000 G. This occurred 5-20 minutes 
after blood collection. Following centrifugation, the plasma was separated from the packed 
red blood cells into the labelled tube. Yellow-tipped micropipettes were used to complete 
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this procedure as it was difficult to utilise a plastic pasteur pipette for such a small volume. 
An average plasma volume of 160µl was obtained from 500µl of blood. Samples were 
stored in the freezer at -80ºC for one to four weeks. 
 
4.6.4 Plasma Analysis 
Plasma glucose concentration was measured using the glucose hexokinase method on a 
Cobas c311 auto analyser (Roche Diagnostics, Indianapolis, IN, USA) (Appendix H). A 
Roche enzymatic colorimetric kit was used to run the test. Once the samples were defrosted, 
plasma glucose concentration was determined within 120 minutes. 
 
Two controls, Precinorm U and Precipath U, were used to enable the range of expected 
concentrations in the samples to be captured so that values could be interpolated. A two-
point calibration was conducted after reagent lot change and as required following quality 
control procedures. These measures ensured quality control throughout testing. Coefficients 
of variation (CV) were 1.25%, 0.67% and 1.87% for Roche commercial control material 
one, Roche commercial control material two and pool plasma, respectively. These values 
were generated by dividing the mean from the standard deviation (SD), and multiplying the 
product by 100.  
 
4.7 Study Procedure 
Participants completed a VAS questionnaire (43) (Appendix I) at baseline, 30, 60, 90, 120 
and 150 minutes as a subjective measure of satiety. The VAS questionnaire comprised of 
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four questions which were answered by marking a vertical line on the 100mm continuum. 
This represented the degree to which the participants associated with the statements at either 
end. The VAS questions included: How hungry do you feel? How satisfied do you feel? 
How full do you feel? How much do you think you can eat? On the left-hand side of the 
VAS, statements from questions one and four indicated extreme fullness, whereas 
statements from questions two and three indicated extreme hunger.  
 
The VAS questionnaire (Appendix I) was shown to participants prior to data collection. 
This was to familiarise participants with the layout and requirements of the visual analogue 
scales to enhance the accuracy of the subjective satiety data. Participants completed one 
VAS questionnaire at each time period on both testing days. 
 
Data entry was only undertaken by the candidate in order to remove between-person 
variability. Measurements were taken to the nearest millimetre and were rounded down if 
the mark intersected the scale at 0.5mm values.  
 
4.8 Dietary Analysis 
Kai-culator dietary assessment software (Human Nutrition, University of Otago) was used 
throughout the study. Following the completion of all testing days, participants entered their 
weighed diet records from both sessions into Kai-culator. This enabled the candidate to gain 
full access to the participants’ records for subsequent analysis. All diets were sorted to 
identify any outliers in energy intake or missing data. This ensured that human error was 
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minimised as participants entered their own diets using only an online “Kai-culator how-to” 
sheet for guidance (Appendix J).  
 
The mean and 95% confidence interval (CI) were generated by subtracting subsequent 
energy intake on day two from day one following the consumption of the trifles. 
4.9 Statistics 
4.9.1 Statistical Methods 
In addition to analysing each of the four satiety questions separately, an overall appetite 
scale was calculated as the average area under the curve (AUC) of the four questions. In the 
case that missing data were present for any one of the four questions, when calculating the 
overall appetite scale the missing data were imputed as the average of the other questions. 
Cronbach’s alphas were calculated for the overall appetite scale at each time point and 
averaged.  
 
AUC was calculated between baseline and 150 minutes using the ‘pkexamine’ command in 
Stata, using cubic splines. If there were missing data at the first or last time point AUC was 
not calculated.  
 
Differences in appetite question and scale AUC were determined using mixed effects 
regression analysis with participant identification as a random effect. Estimates were 
adjusted for the randomised order in which the participants received their trifles and score 
before they began eating. Analysis was also undertaken for standardised AUC to enhance 
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interpretation of the results. The same method was used to estimate differences in 
subsequent energy intake. 
 
A p-value of <0.05 was considered statistically significant. VAS satiety data were analysed 
using Stata Statistical Analysis Software (version 13.1, Stata Corporation 2008).  
The primary outcome of this study was to investigate whether low GI foods keep you 
feeling fuller for longer (50).  
 
4.9.2 Sample Size Estimation  
Mixed regression models were used to determine the differences between trifles with a 
random effect for participant identification and adjustment for randomised order. A study 
sample size of 60 was required to detect a difference of 0.5 standard deviations for all 
outcomes in standardised form. The study had 90% power to the 1% significance level to 






Participant flow can be seen in Figure 4.1. Following randomisation, two participants who 
were randomised to receive the sucrose-sweetened trifle withdrew from the study due to 
lack of enjoyment over the trifle. Three participants withdrew from the sucrose-sweetened 
trifle group after the first session due to lack of enjoyment over the trifle (n=2) and illness 
(n=1). Additionally, three participants from the isomaltulose-sweetened trifle group 
withdrew from the study after the first session due to illness (n=2) and dislike of finger-
pricking (n=1). Twenty-three participants did not finish the entire trifle across both testing 
days. Three participants were excluded from AUC analysis due to missing data. 
 
5.1 Group Demographic Comparison 
Baseline participant characteristics are presented in Table 5.1. Participants were between 
the ages of 19 and 51 (as of 3rd April, 2017), with 90.9% of those under the age of 24. 
68.2% of the study population were within the healthy BMI range (18.5-24.9kg/m2), with 
36.4% being classified as overweight or obese. The majority of the test subjects were female 
and of New Zealand European descent. 
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Table	5.1	Baseline	demographics	and	clinical	characteristics	










































5.2 Blood Glucose 
5.2.1 Evaluation of Plasma Blood Glucose Concentrations  
The mean (SD) blood glucose concentrations at baseline, 60 and 120 minutes are presented 
in Table 5.2. Blood glucose rose at 60 minutes then declined at 120 minutes, though 
remained above baseline for both trifles. A statistically significant difference between trifles 







Time	(minutes)	 Sucrose	 Isomaltulose	 Mean	(95%	CI)	difference	(Isomaltulose	–	sucrose)	
01	 5.2	(0.7)	 5.1	(0.7)	 -0.11	(-0.28,	0.07)	
60	 7.3	(1.7)	 6.7	(1.1)	 -0.69	(-1.12,	-0.25)	




5.3.1 Area under the curve  
AUC was chosen as the best measure of appetite response across the testing time period on 
both days, spanning baseline (prior to trifle ingestion) to 150 minutes postprandial. This 
included a total of six VAS questionnaires by each participant on a given testing day.  
 
The higher the AUC, the higher the participant’s appetite response to the trifle. AUC for all 
four questions were obtained, as well as the overall appetite scale, which was a combination 
of the questions one to four. This additional marker utilised the same 100mm scale as those 
questions in the VAS questionnaire. The questionnaire presented opposing statements on the 
left-hand side of the continuum for questions one and four compared to two and three. 
In contrast to a similar trial (51), the current study used AUC instead of iAUC to measure 
satiety. This was because iAUC does not take the degree of immediate satiety into account 
following the consumption of the trifles. Therefore, any initial differences in satiety between 
the isomaltulose- and sucrose-sweetened trifle would be overlooked by iAUC. The measure 
represented each participant’s total appetite response to the trifle, rather than simply how 
their appetite changed after eating it.  
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As shown in Table 5.3, there were no significant differences in mean AUC for each 
question following consumption of the trifles. Subsequently, as AUC is a difficult measure 
to interpret, mean standardised differences were calculated to allow for further investigation 
of the confidence intervals, which also provided further evidence of the validity of the 
results from the current study. The effects were standardised in terms of standard deviation 
in order to standardise the mean (mean=0, SD=1). Therefore, this allowed the unit 
measurement to be standard deviations. Additionally, a meaningful effect was ruled out as 
the mean difference and 95% CI were all under 0.3 standard deviations. 0.5 standard 
deviations suggests a moderate effect size, which was therefore not detected in the current 
study. Therefore, it is extremely unlikely that there was a difference in satiety between the 
trifles.  
 
Cronbach’s alpha, a measure of internal reliability, was calculated at each time point and 
ranged from 0.86-0.94. Values >0.7 indicate very good reliability (52), therefore the current 
study can conclude that the aim was measured with very high internal reliability and hence, 
good justification to combine these questions into an overall scale of appetite.  
 
Adjustment for special diets, such as vegan or a dairy allergy, did not influence the results. 
Also, a sensitivity analysis was run that included whether the participants finished their 




















How	hungry	do	you	feel?	 3628(2457)	 3697(2454)	 37(-616-691)	 0.02	(-0.25,	0.28)	 0.97	
How	satisfied	do	you	feel?	 4928(2506)	 4886(2667)	 -97(-717-523)	 0.04	(-0.28,	0.20)	 0.91	
How	full	do	you	feel?	 4768(2668)	 4899(2859)	 23(-673-718)	 0.01	(-0.24,	0.26)	 0.76	
How	much	do	you	think	you	can	eat?	 4718(2777)	 4729(2979)	 9(-600-617)	 0.00	(-0.21,	0.22)	 0.95	
Overall	appetite	scale	 4493(2393)	 4527(2590)	 -9(-589-572)	 0.00	(-0.24,	0.23)	 0.98	
 
5.4 Subsequent Energy Intake 
Subsequent energy intake between the trifles was not significantly different. However, there 
was a tendency for energy intake to be higher after consumption of the isomaltulose-
sweetened trifle, when compared to the sucrose-sweetened trifle. Subsequent energy intake 
was 364kJ (95%CI: -110, 838; p=0.133, n=66) higher after ingestion of the isomaltulose-
sweetened trifle. A sensitivity analysis was run that excluded those participants who did not 
consume the full portion of their trifle. However, this did not affect the results (343kJ, 95% 




The aim of the current study was to determine the effect of test foods having different 
glycaemic indices on satiety and blood glucose within a healthy New Zealand adult 
population. This study tested the hypothesis surrounding claims that low GI foods keep you 
feeling fuller for longer (50).  
 
Blood glucose rose at 60 minutes following the consumption of the isomaltulose- and 
sucrose-sweetened trifle, then declined at 120 minutes, though remained above baseline for 
both trifles. A statistically significant difference was not observed between trifles at 60 
minutes following consumption. However, the test conditions of the current study made it 
difficult to generate a maximal difference in glycaemic response between the trifles without 
overcompensating for feelings of fullness. This is likely to be because the commercial GI 
testing of the trifles prior to the sessions was conducted under stricter conditions.  
 
Mean satiety AUC did not significantly differ between the isomaltulose- and sucrose-
sweetened trifles. Although there was also no significant difference in subsequent energy 
intake between the trifles, energy intake following the consumption of the isomaltulose-
sweetened trifle tended to be higher than that of the sucrose-sweetened trifle.  
 
To date, no other studies have evaluated the relationship between postprandial glycaemia 
and satiety, whilst using isomaltulose to lower the GI in order to do so. However, this study 
showed that the overall GI of a meal is affected by its individual components, thus altering 
the end GI. As shown in Table 2.1, the current study is novel in that previous literature have 
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not controlled for all other factors other than the glycaemic indices between treatments. 
Thus, the validity of their findings may have been affected.  
 
In this study, to minimise the effect on GI of non-sugar ingredients, the trifles contained as 
much sugar as possible to maximise the difference in GI between trifles. However, this led 
to the serving size being too large as 23 participants did not finish the entire trifle across 
both testing days. This was also in part due to the acute sweetness of the trifles that 
decreased its overall palatability. 
 
Both trifles were classified by GI testing as low despite the fact that the GI of isomaltulose 
alone is 32 (low GI) and the GI of sucrose alone is 65 (medium GI). Therefore, regardless of 
the fact that all food factors apart from the rate of digestion of the sugar were controlled for, 
the co-ingestion of fat (53) and protein (25) led to the convergence of the trifle glycaemic 
indices. Nevertheless, a GI differential of 11 was obtained in the current study. This is 
approximately the population difference found in dietary GI between the lowest (63) and 
highest (78) quintile (54). In practical terms, a GI difference of 11 between trifles is 
realistically achievable in the home setting. This study’s GI differential value is likely to 
have impacted the results. It may have prevented a further increase in the tendency of 
subsequent energy intake to be higher following the consumption of the isomaltulose-
sweetened trifle, compared to that of the sucrose-sweetened trifle. Hence, a significant 
difference in subsequent energy intake may have been seen between trifles.  
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This study was an acute trial where participants attended two testing days, with two to three 
weeks washout. This differed from other studies with similar findings. Two longer-term 
studies were conducted over eight days (49) and two consecutive 12-week periods (55). It 
was found in the eight-day trial that there were no significant differences in satiety, food 
intake or glycaemic and insulinaemic responses between diets consisting of either high and 
low GI foods (49). The 24-week trial also found no differences in energy intake or 
subjective satiety ratings between diets containing either high and low GI carbohydrate-rich 
foods (55). Therefore, despite the differences in study duration between the current study 
and other trials with similar findings ((55), (49)), study duration does not appear to 
influence the results.  
 
Several studies have found a relationship between glycaemic response and satiety ((36), 
(50), (38), (35)). Claims that low GI foods will keep you feeling fuller for longer have 
arisen from a four-week randomised, crossover controlled feeding study by Chang et al. 
(50). It was found that compared to a high glycaemic load (GL) diet, a low GL diet 
significantly increased overall satiety by 7% (p=0.03), and decreased hunger in women 
(p<0.01). Unlike the current study, the use of a diverse sample population enabled many 
subgroup analyses between BMI, gender, percentage body fat and ethnicity to be conducted. 
However, no differences were found (50). Therefore, it is unlikely that repeating the current 
study with a more diverse population would affect the results. However, the design by 
Chang et al. is confounded by fibre content as it greatly differed between diets being higher 
on the low GL diet by 27g. Therefore, it is likely that the consumption of considerably more 
fibre contributed to the increase in satiety on the low GL diet. Discrepancies in fibre may 
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also have been a factor in a study more than two decades previously (35). Bean flakes were 
used to determine the effects of slow release carbohydrates on plasma glucose and satiety. 
Findings showed that compared to a potato meal, the bean meal prolonged satiety and 
decreased the desire to consume a palatable snack. However, the sample size was small 
(n=6) and the bean meal contained substantially more fibre than the potato meal. From this, 
it is evident that the strengths of the current study become apparent when the study designs 
from previous trials are considered. The current study was novel in the fact that the energy 
and macronutrient content did not differ between trifles. This meant than any differences 
between trifles could be clearly attributable to GI.  
 
A review outlined plausible reasons as to why there is no consensus regarding the 
relationship between glycaemic response and satiety (56). It was suggested that within the 
contradictory literature, a food’s GI is often falsely attributed to feelings of fullness. As 
shown in Table 2.1, there are a lack of studies that measure blood glucose, energy intake 
and appetite simultaneously over an extended period of time. These ideas seem feasible in 
the ongoing debate regarding the inconsistencies in the relationship between GI and satiety. 
The review proposed that in the short-term, high GI carbohydrates are better for satiety; 
whereas over longer periods of time, low GI carbohydrates are better for satiety (56). This is 
aligned with the glucostatic theory (explained in 1.5.3) as it was suggested that the impact 
of GI on satiety is influenced by factors other than their effect on blood glucose.  
 
It is difficult to deduce viable reasons for the difference in findings between the current 
study and a number of other conflicting studies ((38), (50), (35)). Many variables have been 
	 	 	40	
identified from these studies that are likely to confound the results. One review (57) 
suggested that prior to food arriving in the gut, the cognitive and sensory signals associated 
with food have an impact on satiety.  
6.1 Strengths and Limitations 
The current study used a convenience sample of healthy, young adults, who were mostly 
female (86.8%). Thus, this limits the applicability of the findings to the wider population. 
However, the use of a crossover study design strengthened this trial as participants acted as 
their own controls. This enabled the entirety of the sample population (n=66) to be included 
in the intervention analysis.  
A fundamental strength of this study was that blood glucose samples were taken at the time 
of completing the VAS questionnaire. This enabled subjective satiety at each time point to 
be validated by an objective blood glucose measure. Additionally, the GI values from this 
study were obtained from the trifles themselves, rather than from external sources.  
A limitation for this study was that participants generally utilised the full 20 minute time 
period to consume their trifle. Therefore, though tested in 12 participants, GI testing was 
able to elicit a truer value for the glycaemic responses produced by the trifles. 
6.2 Conclusion 
The current study was the first of its calibre to assess the effects of postprandial glycaemia 
on satiety in healthy young adults. Findings showed no significant differences in mean 
satiety AUC or subsequent energy intake between the trifles. Blood glucose rose at 60 
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minutes following consumption and subsequently declined to above baseline levels at 120 
minutes, resulting in a statistically significant difference at 60 minutes. 
 
Under these study conditions, satiety was independent of the glycaemic response. Thus, 
caution should be taken when considering claims surrounding satiety and postprandial 
glycaemia. Despite the rapidly increasing prevalence of obesity and non-communicable 
diseases in New Zealand (58), selecting foods based solely on glycaemic response may not 
be an effective solution. 
 
7. Application to Practice 
The practical translation of the GI concept is to swap high GI carbohydrates for low or 
moderate GI counterparts (59). Following this advice, the main carbohydrate ingredient in 
trifle (sucrose; medium-high GI) was exchanged for isomaltulose (low GI) and the effect on 
satiety between trifles containing one or other of these sugars was assessed. Despite a 
difference in glycaemic response at 60 minutes following consumption, there was no 
difference in subjective ratings of satiety or objective estimates of subsequent food intake 
between trifles. A key point to take into practice is that the overall GI of a meal or diet is 
likely to be affected by the individual glycaemic indices of the constituent foods or 
ingredients. This is the reason why GI studies are often confounded by comparison foods 
having different composition of protein, fat and fibre, factors that may independently affect 
the relationship between the food and satiety. Hence why it was difficult to compare the 
effects of low GI versus high GI on satiety using trifles that contained exactly the same 
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energy and macronutrient content. Under our test conditions, the glycaemic response was 
not related to satiety or subsequent energy intake. 
 
It is important for dietitians to emphasise that consumption of carbohydrate-rich foods 
should not be based solely on GI. Instead, a focus should be placed on low energy density, 
satiating foods. This recommendation aligns with the Ministry of Health’s Eating and 
Activity Guidelines for New Zealand Adults (60) which emphasises those carbohydrates 






























































































































































































Approval is for up to three years from the date of this letter. If this project has not been
completed within three years from the date of this letter, re-approval or an extension of
approval must be requested. If the nature, consent, location, procedures or personnel of your
approved application change, please advise me in writing.
The Human Ethics Committee (Health) asks for a Final Report to be provided upon



























































































		 Time	 Amount	 Food	 Time	 Amount	 Drink	
Breakfast	
		 		 		 		 		 		
		 		 		 		 		 		 		
		 		 		 		 		 		 		
Snacks	 		 		 		 		 		 		
		 		 		 		 		 		 		
		 		 		 		 		 		 		
Lunch	
		 		 		 		 		 		
		 		 		 		 		 		 		
		 		 		 		 		 		 		
Snacks	
		 		 		 		 		 		
		 		 		 		 		 		 		
Dinner	 		 		 		 		 		 		
		 		 		 		 		 		 		
		 		 		 		 		 		 		
Snacks	 		 		 		 		 		 		
		 		 		 		 		 		 		



































































































































Name of person taking consent  Date: 




















































• Indicates cobas c systems on which reagents can be used
Order information Roche/Hitachi cobas c systems
Glucose HK cobas c 311 cobas c 501/502
800 tests Cat. No. 04404483 190 System-ID 07 6831 6 • •
Calibrator f.a.s. (12 x 3 mL) Cat. No. 10759350 190 Code 401
Calibrator f.a.s. (12 x 3 mL, for USA) Cat. No. 10759350 360 Code 401
Precinorm U plus (10 x 3 mL) Cat. No. 12149435 122 Code 300
Precinorm U plus (10 x 3 mL, for USA) Cat. No. 12149435 160 Code 300
Precipath U plus (10 x 3 mL) Cat. No. 12149443 122 Code 301
Precipath U plus (10 x 3 mL, for USA) Cat. No. 12149443 160 Code 301
Precinorm U (20 x 5 mL) Cat. No. 10171743 122 Code 300
Precipath U (20 x 5 mL) Cat. No. 10171778 122 Code 301
PreciControl ClinChem Multi 1 (20 x 5 mL) Cat. No. 05117003 190 Code 391
PreciControl ClinChem Multi 1 (4 x 5 mL, for USA) Cat. No. 05947626 160 Code 391
PreciControl ClinChem Multi 2 (20 x 5 mL) Cat. No. 05117216 190 Code 392
PreciControl ClinChem Multi 2 (4 x 5 mL, for USA) Cat. No. 05947774 160 Code 392
Diluent NaCl 9 % (50 mL) Cat. No. 04489357 190 System-ID 07 6869 3
English
System information
For cobas c 311/501 analyzers:
GLUC3: ACN 717
SGLU3: ACN 668 (STAT, reaction time: 7)
For cobas c 502 analyzer:
GLUC3: ACN 8717
SGLU3: ACN 8668 (STAT, reaction time: 7)
Intended use
In vitro test for the quantitative determination of glucose in human serum,
plasma, urine and CSF on Roche/Hitachi cobas c systems.
Summary1,2,3
Glucose is the major carbohydrate present in the peripheral blood. Oxidation
of glucose is the major source of cellular energy in the body. Glucose
derived from dietary sources is converted to glycogen for storage in the
liver or to fatty acids for storage in adipose tissue. The concentration of
glucose in blood is controlled within narrow limits by many hormones, the
most important of which are produced by the pancreas.
The most frequent cause of hyperglycemia is diabetes mellitus resulting
from a deficiency in insulin secretion or action. A number of secondary
factors also contribute to elevated blood glucose levels. These include
pancreatitis, thyroid dysfunction, renal failure and liver disease.
Hypoglycemia is less frequently observed. A variety of conditions may cause
low blood glucose levels such as insulinoma, hypopituitarism or insulin
induced hypoglycemia. Glucose measurement in urine is used as a diabetes
screening procedure and to aid in the evaluation of glycosuria, to detect
renal tubular defects, and in the management of diabetes mellitus. Glucose
measurement in cerebrospinal fluid is used for evaluation of meningitis,
neoplastic involvement of meninges and other neurological disorders.
Test principle
UV test
Enzymatic reference method with hexokinase4,5





Glucose-6-phosphate dehydrogenase oxidizes glucose-6-phosphate in
the presence of NADP to gluconate-6-phosphate. No other carbohydrate
is oxidized. The rate of NADPH formation during the reaction is directly
proportional to the glucose concentration and is measured photometrically.
G-6-P + NADP+
G-6-PDH
gluconate-6-P + NADPH + H+
Reagents - working solutions
R1 MES buffer: 5.0 mmol/L, pH 6.0; Mg2+: 24 mmol/L; ATP: ≥ 4.5 mmol/L;
NADP: ≥ 7.0 mmol/L; preservative
R2 HEPES buffer: 200 mmol/L, pH 8.0; Mg2+: 4 mmol/L; HK (yeast):
≥ 300 µkat/L; G-6-PDH (E. coli): ≥ 300 µkat/L; preservative
R1 is in position B and R2 is in position C.
Precautions and warnings
For in vitro diagnostic use.
Exercise the normal precautions required for handling all laboratory reagents.
Safety data sheet available for professional user on request.





Shelf life at 2-8 °C: See expiration date on
cobas c pack label.
On-board in use and refrigerated on the analyzer: 8 weeks
Diluent NaCl 9 %
Shelf life at 2-8 °C: See expiration date on
cobas c pack label.
On-board in use and refrigerated on the analyzer: 12 weeks
Specimen collection and preparation
For specimen collection and preparation, only use suitable
tubes or collection containers.
Only the specimens listed below were tested and found acceptable.
Serum.
Plasma: Li-heparin, K2-EDTA, NaF/Na2EDTA, KF/Na2EDTA, NaF/K-Oxalate.
Collect blood by venipuncture from fasting individuals using an evacuated
tube system. The stability of glucose in specimens is affected by storage
temperature, bacterial contamination, and glycolysis. Plasma or serum
samples without preservative (NaF) should be separated from the cells or
clot within half an hour of being drawn. When blood is drawn and permitted
to clot and to stand uncentrifuged at room temperature, the average
decrease in serum glucose is ~ 7 % in 1 hour (0.28 to 0.56 mmol/L or
5 to 10 mg/dL). This decrease is the result of glycolysis. Glycolysis can
be inhibited by collecting the specimen in fluoride tubes.1
The sample types listed were tested with a selection of sample collection tubes
that were commercially available at the time of testing, i.e. not all available
tubes of all manufacturers were tested. Sample collection systems from
various manufacturers may contain differing materials which could affect































































































How to use ‘Kai-culator’- instructions HUNT311, 2017 
Logging on: 
Open the Firefox or Chrome web browser 
Type https://sybil.otago.ac.nz/dietary/opening.das? into the address line 
The ‘username’ is your university user name and the ‘password’ is your student ID number 
There are clickable ‘Help ’  and ‘FAQ’  icons at the bottom right of most screens which give instructions for 
each screen. Below is a summary of what you need know. 
1. How to enter a diet within a project 
Select the project e.g. HUNT311 > select Diets > select Records > select New 
2. Set up the record 
Record the Record ID number, usually the study participant ID number. Kai-culator produces a default ID RRRXXX 
but override this with your chosen ID e.g. your name to make up 6 letters with no spaces in between. NB be careful 
when you record the ID. You cannot change it if you make a mistake. You can e-mail Liz to change an ID for you. 
Send her the incorrect ID and the new correct ID.  
• Select Day# and Type in 1 or subsequent day number  
• Select date that diet was recorded from drop down menu 
• Select Start 
1. Record food names - two-step process  
• Type the first food item in the Diary item field. Keep it broad to start with by recording e.g. ‘milk’ rather 
than the specific type/ brand. You don’t need to write measurements/ quantities in at this stage.  
• To select time click the up/down arrows to find the correct meal time or type the time in 24-hour clock 
format. It’s best if you record the time in at this stage. Click   or  the ‘Return’ key between food items. 
Add more food items. Click the ‘Save’  icon. 
• Click the ‘Continue diet record’  icon below the table to go to the next screen. 
• Now choose the specific foods from the Food list items to match your descriptions.  
• Clicking on foods in the Food item column triggers an automatic search for matching/close items from the 
Food list items (below Food diary) If a match still does not exist see the hints below. 
• A food match is selected by double-clicking it. Its description is now entered into the diet. 
• Changes are not automatically saved - a green corner in a table cell means unsaved data   








Hints: The foods displayed in the Food list items can be expanded or contracted by changing the 
selection criteria in the fields ‘Starts with’ and ‘contains’ 
a) Frequently the first word is a generic name such as ‘bread’ or ‘beef’ 
b) Leave the ‘contains’ field blank to see all the options for foods that start with the selected 
name in ‘Starts with’. Add a descriptor in the ‘contains’ field to shorten the list to foods 
containing the descriptor, e.g., wholemeal or porterhouse.  
c) If ‘Starts with’ does not find the food you are looking for choose ‘Contains’ from the drop 
down list and click search. 
d) To see all of the foods in a food group click on the drop down box and select the food 
group name. Scroll up and down to familiarise yourself with foods in the database. (Note: 





• Enter the food amounts. Click on Amount for each food and select the appropriate amount from the three 
methods available; grams; measure descriptors; volume/shape. NB: mls won’t work on the left hand box 
when typing in quantities. You have to enter liquids on the right hand box and select mls as the unit and 









There are two ways to create new recipes within ‘Kai-culator’;  
• New project ‘List’ recipes. This method is useful for recording generic recipes or for participants own 
recipes where they have recorded the raw ingredient weights or measures and then cooked the food.  
• Recording a participant’s own recipe within their diet record. This method is useful for foods which are 
not cooked, e.g. jelly, a sandwich or an assembly of already cooked ingredients, e.g. cooked pasta, pasta 
sauce and parmesan cheese topping.  
How to create a new ‘Project’ recipe in the project 'Recipe Database' 
• Click on your project e.g. HUNT311 2017 
• Click Composition Data>Recipes 
• Click the  icon 
• Type in the name of your recipe and your initials e.g. spaghettibologneseFK > click ‘OK’. 
• Click the name of the recipe, then click ‘Edit recipe’  icon - new tables appear on the right of the 
screen. The top one is the recipe table. 
• In the recipe table select the cooking method from the drop down menu. 
• Type in the cooking time and temperature (100ºC for boiled, steamed, microwaved; 180ºC for baked, 
roasted, stir-fried, fried. 220ºC for grilled, barbecued). 
• Click 'Save' icon. 
• Record the moisture change value - see hints below. Click 'Save'  icon. 
• Add ingredients - see hints below. Click 'Save'  icon. 
• Record ingredient amounts - Click the ‘Amount’ field and record the amount as grams, or a measure 
descriptor. Click ‘OK’. Click 'Save'  icon. 
• Record the Retention factor - see hints below. Click 'Save'  icon. 
Click the 'Calculate recipe' icon and check that the nutrient values in the left hand right table change from '-0.1g' 
to a positive value. Check the water value is not zero. If it is zero, check you have recorded the moisture change value 













a) Choose only one method for recording an amount as Kai-culator has a hierarchy of 
selection if more than one method is recorded, i.e., a value in the Measure 
descriptor ‘How many’ column takes priority over a value in the Volume ‘How 
many’ field. which takes priority over a value in the Amount column 
b) Click the "Save" icon  to commit these changes. 
c) If there is no density for a food a volume can not be converted to grams and so the 















































Participants’ own recipes  
The participants’ own recipes can be entered within the diet for uncooked recipes, e.g. smoothie, salad or sandwich or 
an assembled cooked food recipes, e.g. pasta and sauce if they have recorded the amounts of raw or cooked 
ingredients and the proportion of the recipe they consumed. If they don’t state the proportion or only state they 
consumed a weighed or measured amount such as ‘125g’ or ‘1 cup’ it might be easier to record their recipe as a ‘List 
recipe’, see above. 
How to enter a participant’s own recipe within a diet record as cooked ingredients and raw 
amounts  
• Click ‘Food item’ cell so it turns pink > Click the recipe icon on the right of the same line (A new 
recipe screen will come up) 
• To add new ingredients Click  icon 
• Type in the name of the first ingredient  > Click OK. 
Hint: How to record the moisture change value 
Moisture change values are found in two places in Kai-culator… 
‘Kai-culator’ recipes – within a project the ANS0809 recipes can be found in 'Composition 
Data /Recipe Database' then click the 'Switch view' icon. 
• Search for a similar recipe. Type food name in ‘Starts with’ field and click 
‘Search’. 
• Click on an appropriate recipe and click on the ‘View recipe’  icon. 
• Note the moisture factor. 
USDA moisture factors list is found in the main Kai-culator menu 




Hint: How to add ingredients 
• Click the icon. The ingredient number appears. 
• Click in the 'Food item' field which will turn pink. 
• Type the ingredient name in the ‘Starts with’ field and click 'Search'. Double click 
on the appropriate ingredient which will appear in the ‘Food item’ field. 
• Note: Make sure you choose raw ingredients for Project Recipes, except where pre-
cooked items are included in a recipe. The moisture change and the retention factors 
will 'cook/convert' raw ingredient nutrient values to cooked values. 
Hint: How to record the retention factor 
• Click the ‘Retention field’ for each ingredient and select the appropriate 
retention factor for the type of food and cooking method from the drop down 
menu. 
• Click ‘Save’. 
• Repeat for all ingredients. 
• Note: Some foods do not have retention factors applied e.g. sugars, fats and 




• Type in the name of the second ingredient > Click OK repeat for all ingredients.  
• Click cancel and return to the Food Diary Reconciliation recipe screen.  Click ‘Save ’  
• Click the ‘Food item’ field for the first ingredient. Check below the table to see if the food item you want 
is in the ‘Food list’, remembering to choose the cooked version of the food if the recipe is an assembly of 












• Click the ‘Amount field’. Enter the amount in the ‘g/ml’ amount field, the measure description field or 
shape field.  
• Repeat the last two steps for all ingredients  
• Click ‘Save recipe’           icon in the bottom left corner of the table 
• Click ‘Exit’ icon (to return to the Food Diary Reconciliation screen 
• Click on the ‘Amount field’ > Type in % the participant consumed> Click OK 
• Click ‘Save’  icon. Click ‘Exit’  icon 
 
 
Hints: The foods displayed in the Food list items can be expanded or contracted by 
changing the selection criteria in the fields ‘Starts with’ and ‘contains’ 
e) Frequently the first word is a generic name such as bread or beef  
f) Leaving the ‘contains’ field blank gives all the options available for 
foods that start with the selected name in ‘Starts with’. Adding a 
descriptor in the ‘contains’ field shortens the list to foods containing 
that descriptor, e.g., wholemeal or porterhouse.  
g) If the ‘Starts with’ field does not find the food you are looking for 
choose ‘Contains’ from the drop down list and click search. 
